MetaADEDB 2.0 @ LMMD
Vardenafil Dihydrochloride
(SECKRCOLJRRGGV-UHFFFAOYSA-N)
Structure
SMILES
CCOc1ccc(cc1c1[nH]c(=O)c2n(n1)c(CCC)nc2C)S(=O)(=O)N1CCN(CC1)CC
Type(s)
Approved
ATC code(s)
G04BE09
Molecular Formula:
C23H32N6O4S
Molecular Weight:
488.603
Log P:
3.0270
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
1
TPSA:
121.28
CAS Number(s):
224785-90-4; 224789-15-5
Synonym(s)
1.
Vardenafil Dihydrochloride
2.
1-(((3-(3,4-dihydro-5-methyl)-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine
3.
Levitra
4.
Vardenafil
5.
Vardenafil Hydrochloride
6.
Vardenafil Hydrochloride Anhydrous
7.
Vardenafil Hydrochloride Trihydrate
8.
Anhydrous, Vardenafil Hydrochloride
9.
Dihydrochloride, Vardenafil
10.
Hydrochloride Anhydrous, Vardenafil
11.
Hydrochloride Trihydrate, Vardenafil
12.
Hydrochloride, Vardenafil
13.
Trihydrate, Vardenafil Hydrochloride
External Link(s)
MeSHD000069058
PubChem Compound135400189
110634
BindingDB14776
50370570
86726
50088373
ChEBI46295
CHEMBLCHEMBL1520
DrugBankDB00862
DrugCentral2809
IUPHAR/BPS Guide to PHARMACOLOGY7320
KEGGdr:D08668
Therapeutic Target DatabaseD0C9SY
ZINC18324776
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 774
Canada Vigilance: 6
Canada Vigilance
US FAERS
2Erectile dysfunctionFAERS: 641OFFSIDES
US FAERS
3HeadacheFAERS: 369
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
4Adverse eventFAERS: 217OFFSIDES
US FAERS
5Erection increasedFAERS: 210
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
6FlushingFAERS: 164
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
7DizzinessFAERS: 90
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
8Drug use for unknown indicationFAERS: 60OFFSIDES
US FAERS
9No adverse eventFAERS: 58US FAERS
10Visual disturbanceFAERS: 58OFFSIDES
SIDER
US FAERS
11NauseaFAERS: 45
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
12BlindnessFAERS: 44SIDER
US FAERS
13ErythemaFAERS: 42SIDER
US FAERS
14PalpitationsFAERS: 40SIDER
US FAERS
15DyspepsiaFAERS: 36OFFSIDES
SIDER
US FAERS
16PriapismFAERS: 36
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
17TinnitusFAERS: 35
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
18Chest PainFAERS: 33SIDER
US FAERS
19VomitingFAERS: 31SIDER
US FAERS
20DeafnessFAERS: 30OFFSIDES
US FAERS
21Unevaluable eventFAERS: 29OFFSIDES
US FAERS
22Back PainFAERS: 28SIDER
US FAERS
23Feeling abnormalFAERS: 27SIDER
US FAERS
24Cerebrovascular accidentFAERS: 26US FAERS
25Visual ImpairmentFAERS: 26
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
26AnorgasmiaFAERS: 24OFFSIDES
US FAERS
27CyanopsiaFAERS: 22
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
28Spontaneous penile erectionFAERS: 22OFFSIDES
US FAERS
29Therapeutic response delayedFAERS: 22US FAERS
30MyalgiaFAERS: 21SIDER
US FAERS
31SyncopeFAERS: 20SIDER
US FAERS
32MalaiseFAERS: 19
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
33HypotensionFAERS: 17
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
34PhotophobiaFAERS: 17
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
35Abdominal discomfortFAERS: 16US FAERS
36Eye painFAERS: 16OFFSIDES
SIDER
US FAERS
37Myocardial InfarctionFAERS: 16
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
38FatigueFAERS: 15US FAERS
39Premature EjaculationFAERS: 15SIDER
US FAERS
40Retinal Vein OcclusionFAERS: 15SIDER
US FAERS
41PainFAERS: 14SIDER
US FAERS
42VertigoFAERS: 14SIDER
US FAERS
43FlatulenceFAERS: 13OFFSIDES
US FAERS
44HypersensitivityFAERS: 13SIDER
US FAERS
45ChromatopsiaFAERS: 12OFFSIDES
SIDER
US FAERS
46DiplopiaFAERS: 12US FAERS
47EpistaxisFAERS: 12OFFSIDES
SIDER
US FAERS
48Pharmaceutical product complaintFAERS: 12US FAERS
49Product quality issueFAERS: 12US FAERS
50TremorFAERS: 12US FAERS
51Wrong technique in drug usage processFAERS: 12US FAERS
52Macular degenerationFAERS: 11US FAERS
53Retinal DetachmentFAERS: 11US FAERS
54AnxietyFAERS: 10OFFSIDES
SIDER
US FAERS
55DysuriaFAERS: 10US FAERS
56PruritusFAERS: 10SIDER
US FAERS
57SomnolenceFAERS: 10SIDER
US FAERS
58TachycardiaFAERS: 10SIDER
US FAERS
59Abdominal PainFAERS: 9SIDER
US FAERS
60ArthralgiaFAERS: 9SIDER
US FAERS
61AstheniaFAERS: 9SIDER
US FAERS
62CataractFAERS: 9US FAERS
63ChillsFAERS: 9US FAERS
64Pulmonary EmbolismFAERS: 9US FAERS
65Retinal Artery OcclusionFAERS: 9OFFSIDES
US FAERS
66Sexual DysfunctionFAERS: 9US FAERS
67Suspected counterfeit productFAERS: 9US FAERS
68Chest discomfortFAERS: 8US FAERS
69RhinitisFAERS: 8OFFSIDES
SIDER
US FAERS
70Blood urine presentFAERS: 7US FAERS
71DysphoniaFAERS: 7US FAERS
72Euphoric moodFAERS: 7OFFSIDES
US FAERS
73Expired product administeredFAERS: 7US FAERS
74Restless Legs SyndromeFAERS: 7US FAERS
75Therapeutic product ineffectiveFAERS: 7US FAERS
76ThrombosisFAERS: 7US FAERS
77AmnesiaFAERS: 6SIDER
US FAERS
78Atrial FibrillationFAERS: 6US FAERS
79Deafness NeurosensoryFAERS: 6OFFSIDES
US FAERS
80Genital burning sensationFAERS: 6OFFSIDES
US FAERS
81Urinary IncontinenceFAERS: 6US FAERS
82UrticariaFAERS: 6US FAERS
83Vitreous DetachmentFAERS: 6US FAERS
84Acute myocardial infarctionFAERS: 5US FAERS
85AsthmaFAERS: 5US FAERS
86BradycardiaFAERS: 5OFFSIDES
US FAERS
87Burning sensationFAERS: 5
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
88ChloropsiaFAERS: 5OFFSIDES
US FAERS
89DehydrationFAERS: 5US FAERS
90Depressed moodFAERS: 5US FAERS
91DisorientationFAERS: 5US FAERS
92DysgeusiaFAERS: 5US FAERS
93Feeling jitteryFAERS: 5US FAERS
94Genital erythemaFAERS: 5OFFSIDES
US FAERS
95HemiparesisFAERS: 5US FAERS
96Medication ErrorFAERS: 5US FAERS
97Vitreous floatersFAERS: 5US FAERS
98Wrong technique in product usage processFAERS: 5US FAERS
99Blood cholesterol increasedFAERS: 4US FAERS
100Drug administration errorFAERS: 4US FAERS
101Genital painFAERS: 4OFFSIDES
US FAERS
102Head discomfortFAERS: 4US FAERS
103Joint swellingFAERS: 4US FAERS
104LymphadenopathyFAERS: 4US FAERS
105Musculoskeletal stiffnessFAERS: 4US FAERS
106NervousnessFAERS: 4US FAERS
107Optic NeuritisFAERS: 4US FAERS
108Poor quality drug administeredFAERS: 4US FAERS
109Pre-existing condition improvedFAERS: 4OFFSIDES
US FAERS
110PresyncopeFAERS: 4US FAERS
111Respiratory arrestFAERS: 4US FAERS
112Semen volume increasedFAERS: 4OFFSIDES
US FAERS
113SwellingFAERS: 4US FAERS
114Therapeutic response unexpectedFAERS: 4US FAERS
115Urinary tract infectionFAERS: 4US FAERS
116Accidental exposureFAERS: 3US FAERS
117Angina PectorisFAERS: 3SIDER
US FAERS
118AspermiaFAERS: 3OFFSIDES
US FAERS
119Blood creatine phosphokinase increasedFAERS: 3SIDER
US FAERS
120Blood follicle stimulating hormone increasedFAERS: 3OFFSIDES
US FAERS
121Blood testosterone increasedFAERS: 3US FAERS
122Choking sensationFAERS: 3US FAERS
123ConjunctivitisFAERS: 3SIDER
US FAERS
124ConstipationFAERS: 3US FAERS
125Deep Vein ThrombosisFAERS: 3US FAERS
126Disease recurrenceFAERS: 3US FAERS
127Drug effect delayedFAERS: 3US FAERS
128Drug therapy changedFAERS: 3OFFSIDES
US FAERS
129Ear discomfortFAERS: 3US FAERS
130Emotional distressFAERS: 3OFFSIDES
US FAERS
131EnuresisFAERS: 3OFFSIDES
US FAERS
132EructationFAERS: 3US FAERS
133Essential TremorFAERS: 3US FAERS
134Extra dose administeredFAERS: 3US FAERS
135Eye RednessFAERS: 3SIDER
US FAERS
136Genital discomfortFAERS: 3US FAERS
137Global AmnesiaFAERS: 3OFFSIDES
US FAERS
138Hypertensive crisisFAERS: 3US FAERS
139HypertrichosisFAERS: 3OFFSIDES
US FAERS
140Impaired work abilityFAERS: 3US FAERS
141Lipoprotein (a) increasedFAERS: 3US FAERS
142Middle insomniaFAERS: 3US FAERS
143Musculoskeletal discomfortFAERS: 3SIDER
US FAERS
144Neck PainFAERS: 3SIDER
US FAERS
145OverdoseFAERS: 3US FAERS
146Pain of skinFAERS: 3US FAERS
147Paraesthesia of genital maleFAERS: 3US FAERS
148Pregnancy of partnerFAERS: 3US FAERS
149Product use issueFAERS: 3US FAERS
150ScotomaFAERS: 3SIDER
US FAERS
151Skin irritationFAERS: 3US FAERS
152Skin noduleFAERS: 3US FAERS
153Sudden deathFAERS: 3US FAERS
154TachyphylaxisFAERS: 3OFFSIDES
US FAERS
155TrismusFAERS: 3US FAERS
156Unexpected therapeutic drug effectFAERS: 3OFFSIDES
US FAERS
157Urinary hesitationFAERS: 3US FAERS
158Urine flow decreasedFAERS: 3US FAERS
159Weight decreasedFAERS: 3US FAERS
160XanthopsiaFAERS: 3US FAERS
161prostatitisFAERS: 3OFFSIDES
US FAERS
162Accidental drug intake by childFAERS: 2US FAERS
163Activities of daily living impairedFAERS: 2OFFSIDES
US FAERS
164Amaurosis FugaxFAERS: 2OFFSIDES
US FAERS
165AmaurosisFAERS: 2US FAERS
166AnhedoniaFAERS: 2US FAERS
167Aortic AneurysmFAERS: 2US FAERS
168Atrioventricular BlockFAERS: 2US FAERS
169BalanoposthitisFAERS: 2US FAERS
170Blood creatine phosphokinase MM increasedFAERS: 2OFFSIDES
US FAERS
171Blood glucose increasedFAERS: 2US FAERS
172Bone painFAERS: 2US FAERS
173BronchospasmFAERS: 2US FAERS
174Cerebral InfarctionFAERS: 2US FAERS
175Dehydroepiandrosterone increasedFAERS: 2OFFSIDES
US FAERS
176Diabetes MellitusFAERS: 2US FAERS
177DiscomfortFAERS: 2SIDER
US FAERS
178Drug diversionFAERS: 2US FAERS
179Drug effect incompleteFAERS: 2US FAERS
180Drug prescribing errorFAERS: 2US FAERS
181Drug screen positiveFAERS: 2US FAERS
182DysarthriaFAERS: 2US FAERS
183DyspareuniaFAERS: 2US FAERS
184Electrocardiogram abnormalFAERS: 2US FAERS
185EpilepsyFAERS: 2US FAERS
186Excessive masturbationFAERS: 2OFFSIDES
US FAERS
187FrustrationFAERS: 2US FAERS
188Gastric pH decreasedFAERS: 2OFFSIDES
US FAERS
189Gastric ulcerFAERS: 2US FAERS
190Gastrointestinal PainFAERS: 2SIDER
US FAERS
191Genital rashFAERS: 2US FAERS
192GlaucomaFAERS: 2SIDER
US FAERS
193GlossitisFAERS: 2US FAERS
194HemiplegiaFAERS: 2US FAERS
195HypertrophyFAERS: 2US FAERS
196HypoventilationFAERS: 2US FAERS
197Impaired driving abilityFAERS: 2US FAERS
198Inappropriate schedule of drug administrationFAERS: 2US FAERS
199IncontinenceFAERS: 2US FAERS
200Incorrect dose administeredFAERS: 2US FAERS
201InfluenzaFAERS: 2SIDER
US FAERS
202Low density lipoprotein increasedFAERS: 2US FAERS
203Male Orgasmic DisorderFAERS: 2US FAERS
204MonoplegiaFAERS: 2OFFSIDES
US FAERS
205Muscle tightnessFAERS: 2US FAERS
206Musculoskeletal PainFAERS: 2US FAERS
207Nasal discomfortFAERS: 2OFFSIDES
US FAERS
208NeuropathyFAERS: 2US FAERS
209No adverse effectFAERS: 2US FAERS
210Nonspecific reactionFAERS: 2US FAERS
211Ocular discomfortFAERS: 2SIDER
US FAERS
212Ocular vascular disorderFAERS: 2US FAERS
213Orgasmic sensation decreasedFAERS: 2US FAERS
214Otitis ExternaFAERS: 2US FAERS
215Penile size reducedFAERS: 2US FAERS
216Perineal painFAERS: 2US FAERS
217Pharyngolaryngeal PainFAERS: 2US FAERS
218PneumoniaFAERS: 2US FAERS
219Portal Vein ThrombosisFAERS: 2US FAERS
220Product packaging issueFAERS: 2US FAERS
221Rash erythematousFAERS: 2US FAERS
222Retrograde amnesiaFAERS: 2US FAERS
223Scrotal irritationFAERS: 2OFFSIDES
US FAERS
224Semen viscosity increasedFAERS: 2US FAERS
225Semen volume decreasedFAERS: 2US FAERS
226SinusitisFAERS: 2SIDER
US FAERS
227Transmission of drug via semenFAERS: 2US FAERS
228VaricophlebitisFAERS: 2OFFSIDES
US FAERS
229Visual acuity reduced transientlyFAERS: 2US FAERS
230jaundiceFAERS: 2US FAERS
231nervous system disorderFAERS: 2SIDER
US FAERS
232AbasiaFAERS: 1US FAERS
233Accidental overdoseFAERS: 1US FAERS
234Acute Coronary SyndromeFAERS: 1SIDER
US FAERS
235AlopeciaFAERS: 1US FAERS
236Altered visual depth perceptionFAERS: 1US FAERS
237AnencephalyFAERS: 1US FAERS
238AngerFAERS: 1US FAERS
239AngioedemaFAERS: 1SIDER
US FAERS
240Aortic Valve StenosisFAERS: 1US FAERS
241AphagiaFAERS: 1US FAERS
242AphasiaFAERS: 1US FAERS
243ArthritisFAERS: 1US FAERS
244AsthenopiaFAERS: 1US FAERS
245AstigmatismFAERS: 1US FAERS
246Atrial FlutterFAERS: 1US FAERS
247Benign Prostatic HyperplasiaFAERS: 1US FAERS
248BlepharitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
249Blood alkaline phosphatase increasedFAERS: 1US FAERS
250Blood creatinine increasedFAERS: 1SIDER
US FAERS
251Blood lactate dehydrogenase increasedFAERS: 1US FAERS
252Blood triglycerides increasedFAERS: 1US FAERS
253Brain HypoxiaFAERS: 1US FAERS
254Cardiac FlutterFAERS: 1US FAERS
255Cardiac discomfortFAERS: 1US FAERS
256Cerebrovascular InsufficiencyFAERS: 1US FAERS
257CheilitisFAERS: 1US FAERS
258Chemical burn of respiratory tractFAERS: 1US FAERS
259Choroidal DetachmentFAERS: 1US FAERS
260ClumsinessFAERS: 1US FAERS
261Coital bleedingFAERS: 1US FAERS
262Counterfeit drug administeredFAERS: 1US FAERS
263CryingFAERS: 1US FAERS
264Deafness PermanentFAERS: 1US FAERS
265DeliriumFAERS: 1US FAERS
266Diabetic FootFAERS: 1US FAERS
267Drug ineffective for unapproved indicationFAERS: 1US FAERS
268Drug screen false positiveFAERS: 1US FAERS
269DysphasiaFAERS: 1OFFSIDES
US FAERS
270Electrocardiogram J wave abnormalFAERS: 1US FAERS
271Electrocardiogram QT interval abnormalFAERS: 1US FAERS
272Expired drug administeredFAERS: 1US FAERS
273Exposure via body fluidFAERS: 1US FAERS
274Exposure via partnerFAERS: 1US FAERS
275Eye irritationFAERS: 1SIDER
US FAERS
276Food PoisoningFAERS: 1US FAERS
277Foreign body sensation in eyesFAERS: 1OFFSIDES
US FAERS
278GangreneFAERS: 1OFFSIDES
US FAERS
279GastritisFAERS: 1SIDER
US FAERS
280General physical health deteriorationFAERS: 1US FAERS
281Genital contusionFAERS: 1US FAERS
282Genital infection fungalFAERS: 1US FAERS
283GoutFAERS: 1US FAERS
284Growth retardationFAERS: 1US FAERS
285Heart sounds abnormalFAERS: 1US FAERS
286HirsutismFAERS: 1US FAERS
287HomicideFAERS: 1US FAERS
288HyperacusisFAERS: 1US FAERS
289HyperchlorhydriaFAERS: 1US FAERS
290HypervigilanceFAERS: 1US FAERS
291Implantable defibrillator malfunctionFAERS: 1US FAERS
292In-stent coronary artery restenosisFAERS: 1US FAERS
293Incorrect route of drug administrationFAERS: 1US FAERS
294InflammationFAERS: 1US FAERS
295Inhibitory drug interactionFAERS: 1US FAERS
296Intentional drug misuseFAERS: 1US FAERS
297Intentional product use issueFAERS: 1US FAERS
298Intermittent ClaudicationFAERS: 1US FAERS
299Intracranial AneurysmFAERS: 1US FAERS
300Intraocular pressure test abnormalFAERS: 1US FAERS
301Joint stiffnessFAERS: 1OFFSIDES
US FAERS
302LabyrinthitisFAERS: 1US FAERS
303LethargyFAERS: 1US FAERS
304Libido disorderFAERS: 1US FAERS
305Ligament ruptureFAERS: 1US FAERS
306Limb discomfortFAERS: 1US FAERS
307Liver AbscessFAERS: 1US FAERS
308LymphoceleFAERS: 1OFFSIDES
US FAERS
309Macular fibrosisFAERS: 1US FAERS
310Male sexual dysfunctionFAERS: 1US FAERS
311Memory impairmentFAERS: 1US FAERS
312Mental impairmentFAERS: 1US FAERS
313MetamorphopsiaFAERS: 1US FAERS
314Migraine with AuraFAERS: 1US FAERS
315Muscle CrampFAERS: 1US FAERS
316Muscle RigidityFAERS: 1SIDER
US FAERS
317NasopharyngitisFAERS: 1US FAERS
318NeuralgiaFAERS: 1OFFSIDES
US FAERS
319Night sweatsFAERS: 1US FAERS
320No reaction on previous exposure to drugFAERS: 1US FAERS
321NocturiaFAERS: 1US FAERS
322Optic NeuropathyFAERS: 1US FAERS
323Optic nerve infarctionFAERS: 1US FAERS
324Oral mucosal erythemaFAERS: 1US FAERS
325Orchitis noninfectiveFAERS: 1US FAERS
326Oropharyngeal discomfortFAERS: 1US FAERS
327Patient dissatisfaction with treatmentFAERS: 1US FAERS
328Pelvic PainFAERS: 1US FAERS
329Penile contusionFAERS: 1US FAERS
330Penile swellingFAERS: 1US FAERS
331Performance status decreasedFAERS: 1US FAERS
332PharyngitisFAERS: 1SIDER
US FAERS
333PleurisyFAERS: 1US FAERS
334PolyuriaFAERS: 1US FAERS
335PregnancyFAERS: 1US FAERS
336Prescription drug used without a prescriptionFAERS: 1US FAERS
337Procedural complicationFAERS: 1US FAERS
338ProctitisFAERS: 1US FAERS
339Product counterfeitFAERS: 1US FAERS
340Product shape issueFAERS: 1US FAERS
341Product supply issueFAERS: 1US FAERS
342ProstatectomyFAERS: 1US FAERS
343Radical prostatectomyFAERS: 1US FAERS
344Reflux gastritisFAERS: 1US FAERS
345RestlessnessFAERS: 1US FAERS
346Retinal migraineFAERS: 1OFFSIDES
US FAERS
347Retrograde ejaculationFAERS: 1US FAERS
348Ruptured cerebral aneurysmFAERS: 1US FAERS
349Semen viscosity abnormalFAERS: 1US FAERS
350Sinus headacheFAERS: 1SIDER
US FAERS
351Skin UlcerFAERS: 1US FAERS
352Skin discomfortFAERS: 1US FAERS
353Skin lesionFAERS: 1US FAERS
354SneezingFAERS: 1US FAERS
355SnoringFAERS: 1US FAERS
356TachyarrhythmiaFAERS: 1SIDER
US FAERS
357TensionFAERS: 1US FAERS
358Testicular hypertrophyFAERS: 1US FAERS
359Therapeutic response changedFAERS: 1US FAERS
360Therapy non-responderFAERS: 1US FAERS
361Thermal burnFAERS: 1US FAERS
362ThirstFAERS: 1US FAERS
363Throat irritationFAERS: 1US FAERS
364ThrombocytopeniaFAERS: 1US FAERS
365Toxicity to various agentsFAERS: 1US FAERS
366UrethritisFAERS: 1US FAERS
367Urinary RetentionFAERS: 1US FAERS
368VIIth nerve paralysisFAERS: 1US FAERS
369Vascular ruptureFAERS: 1OFFSIDES
US FAERS
370Ventricular FibrillationFAERS: 1US FAERS
371Ventricular arrhythmiaFAERS: 1SIDER
US FAERS
372Visual brightnessFAERS: 1OFFSIDES
SIDER
US FAERS
373Vulvovaginal pruritusFAERS: 1US FAERS
374Wheelchair userFAERS: 1US FAERS
375WheezingFAERS: 1US FAERS
376Wrong drug administeredFAERS: 1US FAERS
377Abnormal ejaculationSIDER
378Abnormal visionSIDER
379Acquired diaphragmatic eventrationOFFSIDES
380AcromegalyOFFSIDES
381AgnosiaOFFSIDES
382Alanine Aminotransferase IncreasedSIDER
383Alanine aminotransferase abnormalOFFSIDES
384Alcohol poisoningOFFSIDES
385AmblyopiaOFFSIDES
386AmimiaOFFSIDES
387Anaphylactic shockSIDER
388Anastomotic complicationOFFSIDES
389AngioplastyOFFSIDES
390Antiphospholipid SyndromeOFFSIDES
391ArteriosclerosisOFFSIDES
392Aspartate Aminotransferase IncreasedSIDER
393Aspartate aminotransferase abnormalOFFSIDES
394AtherosclerosisOFFSIDES
395Atrial tachycardiaOFFSIDES
396Autonomic neuropathyOFFSIDES
397Blood albumin abnormalOFFSIDES
398Blood albuminOFFSIDES
399Blood alkaline phosphataseOFFSIDES
400Blood gases abnormalOFFSIDES
401Blood phosphorusOFFSIDES
402Blood potassium increasedOFFSIDES
403Brain scan abnormalOFFSIDES
404BronchitisOFFSIDES
405BruxismOFFSIDES
406Cardiac valve abscessOFFSIDES
407Cerebral sarcoidosisOFFSIDES
408Color blindnessOFFSIDES
409Color vision changeSIDER
410Congenital cystic kidney diseaseOFFSIDES
411Congenital hypertrichosisOFFSIDES
412Congenital tricuspid valve incompetenceOFFSIDES
413Connective tissue inflammationOFFSIDES
414Contact DermatitisOFFSIDES
415Creatine Phosphokinase IncreasedSIDER
416Creatinine increasedSIDER
417Creutzfeldt-Jakob diseaseOFFSIDES
418DebridementOFFSIDES
419DemyelinationOFFSIDES
420DermatitisSIDER
421Diabetes InsipidusOFFSIDES
422Diabetes mellitus inadequate controlOFFSIDES
423Diabetic Autonomic NeuropathyOFFSIDES
424Drug withdrawal headacheOFFSIDES
425Dry skinOFFSIDES
426Ear and labyrinth disordersSIDER
427Electrocardiogram ST segment abnormalOFFSIDES
428Electromechanical dissociationOFFSIDES
429Endodontic procedureOFFSIDES
430EndophthalmitisSIDER
431EpicondylitisOFFSIDES
432EpididymitisOFFSIDES
433Exfoliative rashOFFSIDES
434Feeling of body temperature changeOFFSIDES
435Fistula dischargeOFFSIDES
436Fluid overloadOFFSIDES
437GamblingOFFSIDES
438GastroduodenitisOFFSIDES
439Gingival HyperplasiaOFFSIDES
440GranulocytosisOFFSIDES
441HaemoconcentrationOFFSIDES
442Head titubationOFFSIDES
443Hepatic Vein ThrombosisOFFSIDES
444Hepatic congestionOFFSIDES
445HiccoughOFFSIDES
446House dust allergyOFFSIDES
447Hypoaesthesia facialOFFSIDES
448HypophagiaOFFSIDES
449Increased upper airway secretionOFFSIDES
450InfectionSIDER
451InfestationSIDER
452IritisOFFSIDES
453Keratitis siccaOFFSIDES
454Left atrial dilatationOFFSIDES
455Life expectancy shortenedOFFSIDES
456Loose toothOFFSIDES
457Lower respiratory tract infection bacterialOFFSIDES
458LymphangitisOFFSIDES
459Mastication disorderOFFSIDES
460MastoiditisOFFSIDES
461Nicotine DependenceOFFSIDES
462Nipple painOFFSIDES
463Norepinephrine increasedOFFSIDES
464ObstructionOFFSIDES
465OrchitisOFFSIDES
466OrthopneaOFFSIDES
467OsteomyelitisOFFSIDES
468Pancreatic PseudocystOFFSIDES
469PancreatitisOFFSIDES
470Penile blisterOFFSIDES
471Peripheral embolismOFFSIDES
472Personality ChangeOFFSIDES
473PhlebitisOFFSIDES
474PhotodermatosisOFFSIDES
475Primary sequestrumOFFSIDES
476Productive CoughOFFSIDES
477Promotion of peripheral circulationOFFSIDES
478Pulmonary HypertensionOFFSIDES
479PurulenceOFFSIDES
480RalesOFFSIDES
481RednessSIDER
482Renal tubular necrosisOFFSIDES
483Retinal infarctionOFFSIDES
484RhinorrheaOFFSIDES
485Scleral pigmentationOFFSIDES
486Secondary hypothyroidismOFFSIDES
487Semen viscosityOFFSIDES
488Septic phlebitisOFFSIDES
489ShockSIDER
490Sick Sinus SyndromeOFFSIDES
491Sinus operationOFFSIDES
492Sinus painSIDER
493Soft Tissue InjuriesOFFSIDES
494Splenic InfarctionOFFSIDES
495StarvationOFFSIDES
496Sudden Cardiac DeathSIDER
497SweatingSIDER
498Testicular massOFFSIDES
499Thalamic infarctionOFFSIDES
500Tooth ExtractionOFFSIDES
501Tooth InfectionOFFSIDES
502Unspecified visual lossSIDER
503Violence-related symptomOFFSIDES
504Visual colour distortionsSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.